NOVTNasdaqMiscellaneous Electrical Machinery, Equipment & SuppliesFiscal year ends December 31Also trades as NOVTU
NOVANTA INC
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 5, 2026
$131.52+2.73 (+2.12%)
Close on Oct 19, 2026
- Market cap
- $5.41B
- P/E (TTM)
- 84.3
- Dividend yield
- –
NOVANTA INC revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Automation Enabling Technologies | $500.84M | $490.62M | $499.22M | $534.09M | – | – | – | – | – | – | 51.1% | +2.1% |
| Medical Solutions | $479.77M | $458.63M | $382.44M | $326.81M | $262.06M | – | – | – | – | – | 48.9% | +4.6% |
| Precision Motion | – | – | – | $308.24M | $212.27M | $129.36M | $124.24M | $132.10M | $105.86M | $88.35M | – | – |
| Vision | – | – | – | $277.99M | $262.06M | $261.65M | $271.41M | $232.90M | $183.07M | $122.25M | – | – |
| Photonics | – | – | – | $274.67M | $232.46M | $199.61M | $230.46M | $249.34M | $232.36M | $174.16M | – | – |
| Robotics and Automation | – | – | $273.47M | $308.24M | $212.27M | – | – | – | – | – | – | – |
| Precision Medicine and Manufacturing | – | – | $282.97M | $274.67M | $232.46M | – | – | – | – | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Solutions | – | – | $41.88M | $28.24M | $17.69M | – | – | – | – | – | – |
| Precision Motion | – | – | – | $60.29M | $52.68M | $31.66M | $22.34M | $31.67M | $27.15M | $21.10M | – |
| Unallocated Corporate and Shared Services | – | – | – | – | – | – | – | – | -$29.12M | -$22.09M | – |
| Vision | – | – | – | $28.24M | $17.69M | $16.35M | $21.01M | $8.99M | $7.88M | -$1.28M | – |
| Photonics | – | – | – | $63.76M | $46.79M | $34.00M | $41.99M | $59.29M | $51.66M | $35.22M | – |
| Robotics and Automation | – | – | $48.37M | $60.29M | $52.68M | – | – | – | – | – | – |
| Precision Medicine and Manufacturing | – | – | $69.28M | $63.76M | $46.79M | – | – | – | – | – | – |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $519.01M | $487.11M | $418.27M | $372.35M | $270.83M | $225.76M | $254.28M | $242.24M | $220.58M | $154.76M | 52.9% | +6.5% |
| Rest of Europe | $137.41M | $128.87M | $137.03M | $137.80M | $138.86M | $127.04M | $129.64M | $105.61M | $81.00M | $51.71M | 14.0% | +6.6% |
| Germany | $114.65M | $123.24M | $128.23M | $133.73M | $101.87M | $83.77M | $82.03M | $88.03M | $68.00M | $55.94M | 11.7% | -7.0% |
| Rest of Asia-Pacific | $97.03M | $107.05M | $105.35M | $101.60M | $89.20M | $74.33M | $89.59M | $104.30M | $84.73M | $60.10M | 9.9% | -9.4% |
| China | $93.20M | $84.56M | $73.44M | $97.18M | $95.05M | $70.56M | $59.51M | $66.41M | $56.13M | $44.23M | 9.5% | +10.2% |
| Other Countries | $19.31M | $18.40M | $19.35M | $18.25M | $10.99M | $9.17M | $11.05M | $7.75M | $10.85M | $18.03M | 2.0% | +4.9% |
From the segment and revenue-disaggregation notes of Novanta's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.